217 related articles for article (PubMed ID: 36566957)
1. Insulin resistance in Alzheimer's disease: The genetics and metabolomics links.
Amin AM; Mostafa H; Khojah HMJ
Clin Chim Acta; 2023 Jan; 539():215-236. PubMed ID: 36566957
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
[TBL] [Abstract][Full Text] [Related]
3. Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
Luchsinger JA; Zetterberg H
Int Rev Neurobiol; 2020; 154():51-77. PubMed ID: 32739014
[TBL] [Abstract][Full Text] [Related]
4. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
[TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
Lazar E; Sherzai A; Adeghate J; Sherzai D
Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
Karki R; Kodamullil AT; Hofmann-Apitius M
J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
[TBL] [Abstract][Full Text] [Related]
7. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
[TBL] [Abstract][Full Text] [Related]
8. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease.
Haan MN
Nat Clin Pract Neurol; 2006 Mar; 2(3):159-66. PubMed ID: 16932542
[TBL] [Abstract][Full Text] [Related]
9. The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.
Shen S; Liao Q; Wong YK; Chen X; Yang C; Xu C; Sun J; Wang J
Int J Biol Sci; 2022; 18(3):983-994. PubMed ID: 35173531
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in Alzheimer's disease.
Diehl T; Mullins R; Kapogiannis D
Transl Res; 2017 May; 183():26-40. PubMed ID: 28034760
[TBL] [Abstract][Full Text] [Related]
11. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
12. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
Kang S; Lee YH; Lee JE
Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
[TBL] [Abstract][Full Text] [Related]
13. Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.
Cardoso S; Seiça R; Moreira PI
Adv Neurobiol; 2017; 19():117-150. PubMed ID: 28933063
[TBL] [Abstract][Full Text] [Related]
14. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
Klimova B; Kuca K; Maresova P
Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease.
Moayedi K; Orandi S; Ebrahimi R; Tanhapour M; Moradi M; Abbastabar M; Golestani A
J Cell Physiol; 2022 Jul; 237(7):2838-2861. PubMed ID: 35580144
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
17. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.
Vieira MNN; Lima-Filho RAS; De Felice FG
Neuropharmacology; 2018 Jul; 136(Pt B):160-171. PubMed ID: 29129775
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
[TBL] [Abstract][Full Text] [Related]
19. Genomic linkage between Alzheimer's disease and type 2 diabetes.
Nedjadi T; Haque A; Alam Q; Gan SH; Chaudhary AG; Abuzenadah AM; Damanhouri GA; Kamal MA
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):203-12. PubMed ID: 24059319
[TBL] [Abstract][Full Text] [Related]
20. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
Mittal K; Katare DP
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
